Conclusions Although this study was not powered for a formal comparison, the systemic treatment patterns and outcomes of BCLC-B and C HCC patients seemed comparable, with a possible trend towards better PFS and OS in BCLC-B patients. 27.
← all excerpts
Abstracts of the 2023 Canadian Association of Medical Oncologists Annual Scientific Meeting †
1
—
—